SCHEMBL3848177

SCHEMBL3848177

O=C(Nc1ccc(F)c(Br)c1)c1ccccc1C(=O)c1ccc2n[c][nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ NPC1 O15118 5/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ HPGD P15428 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ BRAF P15056 1/20 0.38
▸ PPARG P37231 1/20 0.37
▸ PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464511 0.88 MAPT (0.44) MAPTCYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL4470605 0.86 NPC1 (0.40) MAPTCYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL4469804 0.85 HTT (0.46) MAPTCYP2C9CYP2C19KDM4EKMT2A
SCHEMBL3850936 0.84 GPR35 (0.43) MAPTCYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL4462942 0.83 FADS1 (0.49) MAPTKMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL3848659 0.81 MEN1 (0.52) MAPTKDM4EALDH1A1KMT2ANPSR1
SCHEMBL4459109 0.81 RAF1 (0.41) MAPTCYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL27901583 0.80 RXFP1 (0.55) —
SCHEMBL3855951 0.80 NPSR1 (0.48) MAPTCYP2C9CYP2C19ALDH1A1KMT2A
SCHEMBL2299039 0.80 RAF1 (0.54) MAPTCYP2C9CYP2C19KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-A1 METHODS OF USING MEK INHIBITORS Exelixis, Inc. (US) 2009-09-23 — — EP claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 — — WO claimed
WO-2008076415-A1 METHODS OF USING MEK INHIBITORS EXELIXIS, INC. (US) 2008-06-26 — — WO claimed
Send feedback